The hemp industry could become one of the U.S.'s biggest now its industrial use had been legalized, says Doug Fine, author of "Hemp Bound".» Read More
Crystal Peoples-Stokes, Democratic New York Assembly member, discusses the failed war on drugs and her newly introduced marijuana regulation and taxation act that would regulate marijuana like alcohol.
NEW YORK, Dec 11- At the Henley Vaporium, one of a growing number of e-cigarette lounges sprouting up in New York and other U.S. cities, patrons can indulge in their choice of more than 90 flavors of nicotine-infused vapor, ranging from bacon to bubble gum.
Having an addict in the family presents a deeply troubling dilemma. How do you help those you love, while protecting your own financial future?
CNBC's Bertha Coombs reports on the race to treat drug-resistant infections.
Ben Livingston, director of the Center for Legal Cannabis, discusses the legalization anniversary event.
KISMAYU, Somalia, Dec 4- Al Qaeda- linked militants, drug smugglers and shadowy criminal networks stand in the way of the Somali federal government's hopes of hiring a foreign firm to manage the lucrative but run-down southern port of Kismayu.
A Colorado medical marijuana dispensary became the first business in the U.S. licensed to sell recreational marijuana.
*Diet drugs and plans a hard sell, despite rising obesity. KALUNDBORG, Denmark, Nov 14- Steam rises from pipes at a giant industrial complex on the edge of the Baltic Sea whose success is a testament to the world's diabetes and obesity epidemic.
An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major clinical study.
London-listed Shire has agreed to buy U.S. company ViroPharma for about $4.2 billion in cash.
The FDA proposed a new rule that would open up generic drugmakers to liability and apply some of the same regulations used for brand manufacturers.
CNBC's Tyler Mathisen, Jon Fortt and Michelle Caruso-Cabrera debate the money to be made from the legalization of marijuana.
Oct 22- Pfizer Inc said it has decided to develop the abuse-resistant painkiller made by its partner Pain Therapeutics Inc, six months after the pharmaceutical giant's comments raised fears it would drop the drug. Pain Therapeutics shares jumped as much as 30 percent in early trading on the Nasdaq.
You've heard of ED. Now there's a drug for PE, made by a 4-year-old start-up. It's designed for men to make their mates happier.
Will.i.am talks to CNBC about the "failure" of the Drug Abuse Resistance Education program and how thousands of Americans are now in prison because of lack of opportunities in their neighborhood.
The FDA is expected to decide on whether to fast track Perjeta for early treatment of breast cancer by Oct. 31.
Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals as part of a broad collaboration to develop neurological medicines.
The cannabis legalization trend is creating jobs in states where laws have been relaxed, and big business is "looking into the industry in a big way," an expert says.
A warning about stock scams involving marijuana related companies has been issued; CNBC's Mary Thompson has the story.
FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.